- Home
- GHG vs ACIU Comparison
GHG vs ACIU Comparison
Compare GHG & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
GHG
GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
Current Price
Current Price
Company Overview
Basic Information| Metric | GHG | ACIU |
|---|---|---|
| Founded | 2004 | 2003 |
| Country | China | Switzerland |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.1M | 213.3M |
| IPO Year | 2018 | 2016 |
Fundamental Metrics
Financial Performance| Metric | GHG | ACIU |
|---|---|---|
| Price | $1.71 | $3.14 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 17.2K | ★ 1.3M |
| Earning Date | 12-26-2025 | 11-04-2025 |
| Dividend Yield | ★ 5.81% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $174,012,060.00 | $5,482,957.00 |
| Revenue This Year | $19.02 | N/A |
| Revenue Next Year | $8.26 | $738.95 |
| P/E Ratio | $6.55 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.66 | $1.43 |
| 52 Week High | $3.25 | $4.00 |
Technical Indicators
Market Signals| Indicator | GHG | ACIU |
|---|---|---|
| Relative Strength Index (RSI) | 29.21 | 55.61 |
| Support Level | $1.66 | $2.54 |
| Resistance Level | $1.89 | $2.99 |
| Average True Range (ATR) | 0.08 | 0.29 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 24.00 | 50.40 |
Price Performance
Historical ComparisonAbout GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.